Global Blood Glucose Monitoring Devices Market 2017-2021

SKU ID :TNV-10355580 | Published Date: 10-Feb-2017 | No. of pages: 86
Table of Contents PART 01: Executive summary PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation by product Global CGM market Global SMBG market Lancets PART 07: Market segmentation by end-user Hospitals and diagnostic laboratories POL Home care settings PART 08: Geographical segmentation BGM devices market in Americas BGM devices market in EMEA BGM devices market in APAC PART 09: Market drivers Growing prevalence of diabetes in the world Technological advances in BGM devices Availability of reimbursement for BGM devices PART 10: Impact of drivers PART 11: Market challenges High cost of BGM devices Intense competition among vendors Undiagnosed population Inaccuracy in reading of BGM devices PART 12: Impact of drivers and challenges PART 13: Market trends Smart watch-based apps Increasing adoption of home healthcare devices Increase in online marketing strategies Increased adoption of bundled product marketing strategy PART 14: Vendor landscape Competitive scenario PART 15: Key vendor analysis Abbott Laboratories Roche Diagnostics LifeScan Medtronic Key companies to watch Other prominent vendors PART 16: Appendix List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Evolution of CGM devices Exhibit 02: Product offerings Exhibit 03: Global BGM devices market: Overview Exhibit 04: Global BGM devices market 2016-2021 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global BGM devices segments analysis 2016 Exhibit 07: Global CGM market share 2016 Exhibit 08: Global glucose monitors market share 2016 Exhibit 09: Factors considered while purchasing a blood glucose meter Exhibit 10: Global CGM market 2016-2021 ($ billions) Exhibit 11: Market metrics analysis of CGM devices Exhibit 12: Global CGM transmitters and receivers market 2016-2021 ($ millions) Exhibit 13: Global CGM glucose sensors market 2016-2021 ($ millions) Exhibit 14: Global insulin pumps market 2016-2021 ($ billions) Exhibit 15: Global SMBG market: Strength and weakness Exhibit 16: Global SMBG market 2016-2021 ($ billions) Exhibit 17: Market metrics analysis of SMBG devices Exhibit 18: Global SMBG test strips market 2016-2021 ($ billions) Exhibit 19: Global SMBG meters market 2016-2021 ($ billions) Exhibit 20: Product matrix for lancets Exhibit 21: Product matrix for lancing devices Exhibit 22: Global lancets market 2016-2021 ($ millions) Exhibit 23: Market analysis of lancets Exhibit 24: Global BGM devices market by end-user 2016 Exhibit 25: Various types of reference measurement services Exhibit 26: Important aspects of a home care BGM device Exhibit 27: Global BGM devices market by geography Exhibit 28: Global BGM devices market by geography ($ billions) Exhibit 29: BGM devices market overview in Americas 2016 Exhibit 30: BGM devices market in Americas 2016-2021 ($ billions) Exhibit 31: BGM devices market overview in EMEA 2016 Exhibit 32: BGM devices market in EMEA 2016-2021 ($ billions) Exhibit 33: Market scenarios in selected European countries Exhibit 34: BGM devices market overview in APAC 2016 Exhibit 35: BGM devices market in APAC 2016-2021 ($ billions) Exhibit 36: Medtronic partnerships in different countries Exhibit 37: Impact of drivers Exhibit 38: Impact of drivers and challenges Exhibit 39: Features of apps based on smart watch Exhibit 40: Global BGM devices market: Vendor ranking 2016 Exhibit 41: Global BGM devices market: Competitive structure analysis 2016 Exhibit 42: Global BGM devices market-competitive landscape Exhibit 43: Strategic success of companies Exhibit 44: Abbott Diagnostics: Strength assessment Exhibit 45: Abbott Diagnostics: Strategy assessment Exhibit 46: Abbott Diagnostics: Opportunity assessment Exhibit 47: Roche Diagnostics: Strength assessment Exhibit 48: Roche Diagnostics: Strategy assessment Exhibit 49: Roche Diagnostics: Opportunity assessment Exhibit 50: LifeScan: Strength assessment Exhibit 51: LifeScan: Strategy assessment Exhibit 52: LifeScan: Opportunity assessment Exhibit 53: Medtronic: Strength assessment Exhibit 54: Medtronic: Strategy assessment Exhibit 55: Medtronic: Opportunity assessment Exhibit 56: Ypsomed: Company overview Exhibit 57: B Braun: Company overview Exhibit 58: Arkray company overview
Abbott Laboratories, Roche Diagnostics, LifeScan, Medtronic, AgaMatrix, Animas, Becton Dickinson, Bioptik Technology, DarioHealth, Dexcom, GlySens, Integrity Applications, International Biomedical, Medisana, MediWise, Menarini Diagnosticos, Nemaura, Nipro Diagnostics, Nova Biomedical. Owen Mumford, Senseonics, TaiDoc Technology.
  • PRICE
  • $2500
    $4000

Our Clients